<DOC>
	<DOCNO>NCT02567721</DOCNO>
	<brief_summary>The purpose study conduct pilot study explore potential use routinely collect data General Practitioner ( GP ) practice conduct enhance safety surveillance seasonal influenza vaccine UK , recommend EMA interim guidance enhance safety surveillance seasonal influenza vaccine EU .</brief_summary>
	<brief_title>Post-authorisation Safety Study ( PASS ) Influenza Vaccine United Kingdom ( UK )</brief_title>
	<detailed_description>Data routinely collect part clinical consultation primary care extract nine General Practitioner ( GP ) practice order estimate medically attend Adverse Events Interest ( AEIs ) , people receive influenza vaccine . This study also actively follow patient expose seasonal influenza vaccination 7 day three nine GP practice use customised card-based adverse drug reaction reporting system , order determine whether active approach surveillance capture high rate AEIs .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>All individual ( age 6 month ) receive seasonal influenza vaccination 9 GP practice 1 September 2015 30 November 2015 . Pregnant woman also include study . â€¢ Only register patient explicitly opt data share excluded analysis .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Post-authorisation safety study ( PASS )</keyword>
	<keyword>Adverse Drug Reaction Reporting Systems</keyword>
	<keyword>Post marketing product surveillance</keyword>
	<keyword>European Medicines Agency ( EMA )</keyword>
	<keyword>Influenza Vaccine</keyword>
	<keyword>Computerized Medical Record System</keyword>
	<keyword>United Kingdom</keyword>
	<keyword>Primary Health Care</keyword>
</DOC>